Unenhanced CT 30 Percent Less Accurate Than Enhanced for ED Evaluation
WEDNESDAY, May 24, 2023 (HealthDay News) -- Unenhanced computed tomography (CT) is 30 percent less accurate than contrast-enhanced CT for evaluating abdominal pain in the emergency department, according to a study published online May 3 in JAMA Surgery.
Hiram Shaish, M.D., from Columbia University in New York City, and colleagues examined the diagnostic accuracy of unenhanced CT in patients admitted to an emergency department with acute abdominal pain. The analysis included 201 consecutive adult emergency department patients who underwent dual-energy contrast-enhanced CT for the evaluation of acute abdominal pain (April 1 to 22, 2017).
The researchers found that the overall accuracy of unenhanced CT was 70 percent (faculty, 68 to 74 percent; residents, 69 to 70 percent). For primary diagnoses, faculty had higher accuracy than residents (82 versus 76 percent; adjusted odds ratio, 1.83), but they had lower accuracy for actionable secondary diagnoses (87 versus 90 percent; odds ratio, 0.57). This difference was driven by faculty making fewer false-negative primary diagnoses (38 versus 62 percent; odds ratio, 0.23) but more false-positive actionable secondary diagnoses (63 versus 37 percent; odds ratio, 2.11). For overall accuracy, interrater agreement was moderate (Gwet agreement coefficient, 0.58).
"Unenhanced CT was approximately 30 percent less accurate than contrast-enhanced CT for evaluating abdominal pain in the emergency department," the authors write. "This should be balanced with the risk of administering contrast material to patients with risk factors for kidney injury or hypersensitivity reaction."
Two authors disclosed ties to the imaging technology industry.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
Guidance Issued for Managing Visual Disorders After Pediatric Concussion
MONDAY, July 18, 2022 (HealthDay News) -- In a policy statement issued by the...
En un pequeño estudio, Ozempic ayudó a personas con diabetes tipo 1 a dejar los tratamientos con insulina
JUEVES, 7 de septiembre de 2023 (HealthDay News) -- El exitoso medicamento...
Following One Death, FDA Warns Hospitals About Giving Probiotics to Preemies
TUESDAY, Oct. 3, 2023 (HealthDay News) -- Federal regulators are cautioning...
Poll Finds Many U.S. Women Confused About Medical Abortion
WEDNESDAY, Feb. 1, 2023 (HealthDay News) -- Changes in U.S. abortion laws have...